Laboratory Screening for a 10-Year-Old Female
For a 10-year-old female without specific symptoms, risk-based screening should be performed based on weight status and risk factors, with metabolic screening (lipids, glucose, liver enzymes) indicated if she has overweight/obesity (BMI ≥85th percentile) plus additional risk factors.
Screening Algorithm by Clinical Scenario
If Overweight or Obese (BMI ≥85th percentile)
Screen for metabolic complications with:
- Fasting lipid panel (total cholesterol, LDL, HDL, triglycerides) 1, 2
- Fasting glucose or HbA1c for diabetes screening 2, 3
- ALT (alanine aminotransferase) for NAFLD screening 4, 1
The 2024 ADA guidelines specifically recommend risk-based screening for type 2 diabetes starting at age 10 years (or onset of puberty, whichever is earlier) in children with overweight/obesity who have one or more additional risk factors 2, 3. These risk factors include:
- First-degree relative with diabetes
- High-risk race/ethnicity (African American, Latino, Native American, Asian American, Pacific Islander)
- Signs of insulin resistance (acanthosis nigricans)
- Maternal history of diabetes or gestational diabetes
Abnormal value thresholds to recognize 1:
- Triglycerides: ≥110 mg/dL (75th percentile); ≥160 mg/dL (90th percentile)
- LDL cholesterol: ≥110 mg/dL (75th percentile); ≥130 mg/dL (90th percentile)
- HDL cholesterol: <35 mg/dL (10th percentile)
- Fasting glucose: ≥100 mg/dL (impaired fasting glucose)
- ALT: >2 SD above laboratory mean
For NAFLD screening specifically, the 2021 KASL guidelines recommend ALT as the preferred screening test in overweight/obese children, with abdominal ultrasound as an adjunct when necessary 4. Boys with ALT ≥26 IU/L or girls with ALT ≥22 IU/L warrant further evaluation.
If Normal Weight (BMI <85th percentile)
No routine metabolic screening is indicated unless specific risk factors are present 2, 3. The evidence shows only 4% of normal-weight children have insulin resistance compared to 47% of those with BMI ≥95th percentile 1.
However, consider screening if:
- Strong family history of early cardiovascular disease
- Clinical signs suggesting metabolic disease (acanthosis nigricans, severe acne, hirsutism)
- Symptoms of diabetes (polyuria, polydipsia, weight loss)
Blood Pressure Measurement
Measure blood pressure at every visit using height percentile-normalized tables 1. Hypertension is defined as BP ≥90th percentile standardized for sex, age, and height.
Important Caveats
Repeat testing frequency: If initial screening is normal, repeat at minimum 3-year intervals, or sooner if BMI increases 2, 3.
Confirmatory testing: For asymptomatic children with abnormal glucose results, repeat testing on a separate day is required for diagnosis 5. The diagnosis can be confirmed either by repeating the same test or by having two different tests (e.g., A1C and fasting glucose) both above diagnostic thresholds.
Distinguishing diabetes types: In overweight/obese children with hyperglycemia, measure islet autoantibodies to distinguish type 1 from type 2 diabetes, as 10% of youth aged 10-17 with type 2 phenotype have islet autoimmunity 5.
Recent evidence on screening uptake: A 2025 study found that only 26% of US youth with obesity were screened for diabetes, dyslipidemia, or NAFLD, and among those screened, 56% had abnormal lipids, 44% had elevated liver enzymes, and 14% had prediabetes or diabetes 6. This highlights both the low screening rates and high yield when screening is performed.
What NOT to Routinely Order
- Complete blood count (not indicated without specific symptoms)
- Thyroid function tests (only if growth concerns or symptoms of thyroid disease)
- Comprehensive metabolic panel beyond glucose (unless specific indication)
- Hemoglobin A1c alone without fasting glucose (both are acceptable, but fasting glucose may be more practical)